Some pharmacy staff from Walgreens, other chains are walking out again — here’s what you need to know

[ad_1] A sign advertises COVID-19 (coronavirus) vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, August 14, 2023. Brian Snyder | Reuters Some pharmacy staff from Walgreens and other drugstore chains are planning to walk out next week in the latest pushback against what they call unsafe working conditions that put both employees and patients…

Read More

Pharmacy staff from Walgreens, CVS say they’re at a breaking point — here’s what their days look like

[ad_1] Signs offering COVID-19 vaccinations are seen outside of a CVS pharmacy in Washington, DC. Mandel Ngan | AFP | Getty Images Many pharmacy employees at some of the largest U.S. drugstore chains say they’re reaching a breaking point.  On top of verifying, filling and dispensing prescriptions, pharmacists and support staff are responsible for administering…

Read More

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

[ad_1] Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition.  Bristol Myers, one of the world’s largest pharmaceutical companies, raked in $10.96 billion in revenue for the third quarter,…

Read More

Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth

[ad_1] Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations on strong sales of its blockbuster cancer drug Keytruda, HPV vaccine Gardasil and surprisingly, its Covid drug Lagevrio.  The pharmaceutical giant also increased its…

Read More

More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study

[ad_1] Eisai on Wednesday said an injectable version of the Alzheimer’s drug Leqembi showed promising initial results in a clinical trial, potentially paving the way for a new and more convenient option for administering the antibody treatment.  However, the injection did not cause lower rates of brain swelling and bleeding, which are Leqembi’s most concerning…

Read More